Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-02-27
AGRXAgile Therapeutics IncAltomari AlfredCEOP - Purchase$2.71+10,000311,611+3%+$27,100
D
2020-02-27
LGNDLigand Pharmaceuticals IncFoehr Matthew WPres, COOS - Sale+OE$110.00-7,225155,449-4%-$794,750
M
2020-02-25
AKROAkero Therapeutics, Inc.Venbio Global Strategic Fund II L.P.10%S - Sale$22.80-5,9043,227,7670%-$134,635
2020-02-24
AXGTAxovant Gene Therapies Ltd.Roivant Sciences Ltd.10%P - Purchase$3.75+5,333,33318,577,380+40%+$19,999,999
2020-02-25
AMAGAmag Pharmaceuticals, Inc.Armistice Capital, LLC10%P - Purchase$8.29+36,0004,444,000+1%+$298,440
D
2020-02-26
REGNRegeneron Pharmaceuticals, Inc.Van Plew Daniel PEVP, General Mgr Industrial OS - Sale+OE$457.23-15,64229,788-34%-$7,152,016
2020-02-25
CBIOCatalyst Biosciences, Inc.Ling Geoffrey M.D.DirP - Purchase$6.23+3,0003,000New+$18,692
D
2020-02-24
MRUSMerus N.V.Throsby MarkEVP, Chief Scientific OfficerS - Sale+OE$17.74-57,08843,815-57%-$1,012,741
M
2020-02-24
TPTXTurning Point Therapeutics, Inc.Cui Jingrong JeanDirS - Sale$52.16-21,0002,170,681-1%-$1,095,422
2020-02-24
FULCFulcrum Therapeutics, Inc.Thomson Peter G.VP Finance, AccountingS - Sale$16.83-5,00028,571-15%-$84,153
2020-02-25
ADROAduro Biotech, Inc.Van Elsas AndreaChief Scientific OfficerS - Sale$3.51-6,823438,367-2%-$23,954
2020-02-24
ADMPAdamis Pharmaceuticals CorpCarlo Dennis J PhdPres,amp; CEOS - Sale$0.60-12,436487,326-2%-$7,505
D
2020-02-25
BCELAtreca, Inc.Cavet GuyChief Technical OfficerS - Sale+OE$20.64-7,10087,758-7%-$146,538
DM
2020-02-25
REGNRegeneron Pharmaceuticals, Inc.Landry Robert EEVP Finance CFOS - Sale+OE$452.49-41425,145-2%-$187,330
2018-11-19
MDGLMadrigal Pharmaceuticals, Inc.Milligan David VDirS - Sale$131.60-10,00020,000-33%-$1,316,000
2020-02-24
ADMPAdamis Pharmaceuticals CorpMarguglio David J.SVP, Chief Business OfficerS - Sale$0.60-9,948341,243-3%-$6,004
2020-02-24
ADMPAdamis Pharmaceuticals CorpHopkins Robert OCFOS - Sale$0.60-8,420317,480-3%-$5,081
2020-02-24
ADMPAdamis Pharmaceuticals CorpDaniels Karen K.VP of OperationsS - Sale$0.60-6,229157,460-4%-$3,759
2020-02-24
ADMPAdamis Pharmaceuticals CorpMoss Ronald B.Chief Medical OfficerS - Sale$0.06-6,229253,195-2%-$396
2018-11-21
MDGLMadrigal Pharmaceuticals, Inc.Milligan David VDirS - Sale$112.54-20,0000-100%-$2,250,800
2020-02-22
ENDVEndonovo Therapeutics, Inc.Collier Alan BrianDirP - Purchase$0.96+10025,8190%+$96
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaTatsis OuraniaSVP, CROS - Sale$233.17-1,29612,738-9%-$302,187
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaSilva Paul MSVP, ControllerS - Sale$233.45-1,08015,101-7%-$252,127
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaSachdev AmitEVP, Chief Patient OfficerS - Sale$233.53-3,37649,987-6%-$788,402
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaParini MichaelEVP, CL, AOS - Sale$233.49-3,02826,838-10%-$707,005
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaLeiden Jeffrey MCEO, PresS - Sale$233.46-10,55093,021-10%-$2,463,046
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaKewalramani ReshmaEVP, CMOS - Sale$233.45-3,63426,626-12%-$848,371
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaArbuckle Stuart AEVP, Chief Commercial OfficerS - Sale$233.74-3,63435,319-9%-$849,418
2020-02-25
VRTXVertex Pharmaceuticals Inc / MaAltshuler DavidEVP, Global Research, CSOS - Sale$233.41-3,02828,902-9%-$706,776
D
2020-02-25
ZTSZoetis Inc.Peck Kristin CCEOS - Sale+OE$138.09-11,92539,874-23%-$1,646,787
D
2020-02-25
AGRXAgile Therapeutics IncPerceptive Advisors LLC10%P - Purchase$3.00+3,000,00014,919,925+25%+$9,000,000
D
2020-02-25
ABTAbbott LaboratoriesMoreland Mary KEVPS - Sale+OE$84.93-40076,804-1%-$33,972
2020-02-24
ALKSAlkermes Plc.Wysenski NancyDirP - Purchase$19.65+6,94011,242+161%+$136,371
2020-02-25
ATXIAvenue Therapeutics, Inc.Vazzano Joseph WalterCFOP - Purchase$9.09+1,20057,863+2%+$10,908
2020-02-25
ATXIAvenue Therapeutics, Inc.Herskowitz NeilDirP - Purchase$9.31+10,000119,663+9%+$93,100
M
2020-02-21
IRWDIronwood Pharmaceuticals IncMallon MarkCEOS - Sale$11.63-7,984303,425-3%-$92,854
2020-02-24
TYMETyme Technologies, Inc.Demurjian Michael10%S - Sale$1.30-20,00024,030,5210%-$26,006
2020-02-21
IRWDIronwood Pharmaceuticals IncMcCourt Thomas APresS - Sale$11.63-4,177221,062-2%-$48,579
2020-02-21
IRWDIronwood Pharmaceuticals IncMacdonald KellyChief Accounting OfficerS - Sale$11.63-3,90083,127-4%-$45,357
2020-02-21
IRWDIronwood Pharmaceuticals IncGilbert Halley EChief Admin Officer, SVPS - Sale$11.63-15,328265,991-5%-$178,265
2020-02-21
IRWDIronwood Pharmaceuticals IncConsylman GinaSVP, CFO, TreasurerS - Sale$11.63-12,501202,787-6%-$145,387
D
2020-02-21
EBSEmergent Biosolutions Inc.Richard RonaldDirS - Sale+OE$65.00-5,15216,395-24%-$334,880
D
2020-02-25
VTVTVtv Therapeutics Inc.Perelman Ronald O10%P - Purchase$1.60+1,250,00034,106,212+4%+$2,000,000
2020-02-21
EBSEmergent Biosolutions Inc.Hauer Jerome MDirS - Sale$70.00-6,57211,752-36%-$460,040
D
2020-02-21
JNJJohnson & JohnsonMongon ThibautEVP, WW Chair, ConsumerS - Sale+OE$147.96-39,22435,815-52%-$5,803,583
2020-02-25
CBIOCatalyst Biosciences, Inc.Lawlor AugustineDirS - Sale$6.10-69,40115,608-82%-$423,506
2020-02-21
CYCNCyclerion Therapeutics, Inc.Huyett WilliamCFOS - Sale$5.12-3,55971,417-5%-$18,222
2020-02-24
REGNRegeneron Pharmaceuticals, Inc.Yancopoulos GeorgePres, Chief ScientificS - Sale$420.17-118,1231,081,055-10%-$49,631,741
D
2020-02-24
REGNRegeneron Pharmaceuticals, Inc.Brown Michael SDirS - Sale+OE$419.00-2,00016,992-11%-$838,001
2020-02-24
IMGNImmunogen, Inc.Ryll ThomasSVP, Technical OperationsS - Sale$4.99-16,79075,624-18%-$83,782
2020-02-24
IMGNImmunogen, Inc.Enyedy Mark JCEOS - Sale$4.99-55,222433,776-11%-$275,558
2020-02-24
IMGNImmunogen, Inc.Berkenblit AnnaSVP, Chief Medical OfficerS - Sale$4.99-25,80398,089-21%-$128,757
2020-02-24
IMGNImmunogen, Inc.Wingrove TheresaSVP of Regulatory AffairsS - Sale$4.99-16,14770,498-19%-$80,574
2020-02-24
IMGNImmunogen, Inc.Barrows CraigEVP, GCS - Sale$4.99-16,492145,275-10%-$82,295
DM
2020-02-20
EBSEmergent Biosolutions Inc.El-Hibri FuadCOB, 10%S - Sale+OE$64.90-23,3187,347,4230%-$1,513,338
AM
2019-06-07
CUECue Biopharma, Inc.Sandercock ColinSVP, GC, SecP - Purchase$7.90+15,12517,125+756%+$119,433
D
2020-02-20
URGNUrogen Pharma Ltd.Pfreundschuh Peter P.CFOS - Sale+OE$29.68-3606,120-6%-$10,685
2020-02-24
INVAInnoviva, Inc.Zhen MarianneChief Accounting OfficerS - Sale$14.78-2,95421,913-12%-$43,660
D
2020-02-21
ZTSZoetis Inc.Alaix Juan RamonDirS - Sale+OE$142.32-120,35396,013-56%-$17,128,639
2020-02-20
CALACalithera Biosciences, Inc.Orford KeithChief Medical OfficerS - Sale$8.00-3,0218,541-26%-$24,168
DM
2020-02-21
CWBRCohbar, Inc.Biunno Jeffrey FrancisCFO, Treasurer, SecretaryS - Sale+OE$1.95-10,00011,000-48%-$19,500
D
2020-02-21
CWBRCohbar, Inc.Cundy Kenneth CChief Scientific OfficerS - Sale+OE$1.90-10,00010,000-50%-$19,000
2020-02-20
AGIOAgios Pharmaceuticals, Inc.Alenson CarmanPrincipal Accounting OfficerS - Sale$53.37-2,427184-93%-$129,529
2020-02-21
VERUVeru Inc.Fisch HarryDir, 10%P - Purchase$4.47+1,0008,098,1210%+$4,470
D
2020-02-21
HZNPHorizon Therapeutics Public Ltd CoWalbert Timothy PCOB, Pres, CEOS - Sale+OE$35.23-93,864856,893-10%-$3,306,829
M
2020-02-19
SPPISpectrum Pharmaceuticals IncMcGahan Keith MGCS - Sale$2.81-6,008131,992-4%-$16,859
M
2020-02-19
SPPISpectrum Pharmaceuticals IncRiga Thomas JEVP, COO, CCOS - Sale$2.80-7,585248,290-3%-$21,216
M
2020-02-19
EMMAEmmaus Life Sciences, Inc.Niihara YutakaCOB, CEO, 10%P - Purchase$1.80+48,00010,564,3370%+$86,580
M
2020-02-19
SPPISpectrum Pharmaceuticals IncTurgeon Joseph W.CEO, PresS - Sale$2.80-10,012416,806-2%-$28,040
DM
2020-02-19
CCXIChemocentryx, Inc.Schall Thomas J.Pres, CEOS - Sale+OE$50.44-78,6812,268,557-3%-$3,968,809
D
2020-02-19
CCXIChemocentryx, Inc.Kanaya Susan MEVP, CFO, Sec.S - Sale+OE$50.13-24,200185,497-12%-$1,213,221
M
2020-02-19
SPPISpectrum Pharmaceuticals IncGustafson Kurt AEVP, CFOS - Sale$2.80-8,066215,892-4%-$22,614
D
2020-02-19
CCXIChemocentryx, Inc.Cappel Markus J.Chief Bus. Officer, TreasurerS - Sale+OE$50.36-42,63176,247-36%-$2,146,698
2020-02-19
KPTIKaryopharm Therapeutics Inc.Shah JatinEVP, Chief Medical OfficerS - Sale$16.48-1,37540,759-3%-$22,663
2020-02-19
KPTIKaryopharm Therapeutics Inc.Frenkel RanChief Dev Operations OfficerS - Sale$16.48-2,97536,066-8%-$49,034
2020-02-19
KPTIKaryopharm Therapeutics Inc.Primiano Christopher BrettEVP, CBO, GC, SecretaryS - Sale$16.48-2,96110,367-22%-$48,803
2020-02-19
KPTIKaryopharm Therapeutics Inc.Shacham SharonPres, CSOS - Sale$16.48-17,6341,311,611-1%-$290,642
2020-02-19
UROVUrovant Sciences Ltd.Sumitomo Chemical Co., Ltd.See Footnote (1)P - Purchase$13.08+103,25022,963,2630%+$1,350,510
2020-02-19
KPTIKaryopharm Therapeutics Inc.Kauffman MichaelCEOS - Sale$16.48-17,6341,311,611-1%-$290,642
2020-02-19
CSTLCastle Biosciences IncKabakoff David SDir, 10%S - Sale$32.03-25,0001,683,577-1%-$800,750
DM
2020-02-19
KNSAKiniksa Pharmaceuticals, Ltd.Paolini John F.SVP, Chief Medical OfficerS - Sale+OE$18.48-32,28018,000-64%-$596,487
A
2020-02-14
SCPHScpharmaceuticals Inc.Ra Capital Management, L.P.10%P - Purchase$8.20+271,9933,518,998+8%+$2,230,343
D
2020-02-20
MGNXMacrogenics IncRisser Eric BlasiusSVP, Chief Business OfficerS - Sale+OE$10.84-50032,468-2%-$5,420
D
2020-02-20
CHMAChiasma, IncMamluk RoniDirS - Sale+OE$4.54-82,1860-100%-$373,124
DM
2020-02-19
ZTSZoetis Inc.Alaix Juan RamonDirS - Sale+OE$143.93-83,77196,013-47%-$12,056,895
D
2020-02-20
ALNYAlnylam Pharmaceuticals, Inc.Maraganore JohnCEOS - Sale+OE$131.85-34,765193,126-15%-$4,583,674
2020-02-19
EVFMEvofem Biosciences, Inc.Culwell KellyChief Medical OfficerS - Sale$7.00-1,000196,226-1%-$7,000
2020-02-19
EVFMEvofem Biosciences, Inc.Barrans RussellChief Commercial OfficerS - Sale$6.50-14,957332,519-4%-$97,221
2020-02-20
VERUVeru Inc.Fisch HarryDir, 10%P - Purchase$4.51+1,0008,097,1210%+$4,510
2020-02-19
QUREUniqure N.V.Kapusta Matthew CCEO, CFO, MDS - Sale$64.56-7,501284,753-3%-$484,256
2020-02-19
TEVATeva Pharmaceutical Industries LtdDrape EricEVP Global OperationsS - Sale$12.51-8,00021,494-27%-$100,080
D
2020-02-18
RARXRa Pharmaceuticals, Inc.Farzaneh-Far RaminChief Medical OfficerS - Sale+OE$46.61-10,5957,132-60%-$493,850
2020-02-18
NKTRNektar TherapeuticsZalevsky JonathanChief R, D OfficerS - Sale$22.35-4,774327,073-1%-$106,699
2020-02-18
NKTRNektar TherapeuticsThomsen Jillian B.SVP, Chief Accounting OfficerS - Sale$22.35-1,394174,086-1%-$31,156
2020-02-18
NKTRNektar TherapeuticsRobin Howard WPres, CEOS - Sale$22.35-8,448385,281-2%-$188,813
2020-02-18
NKTRNektar TherapeuticsLabrucherie Gil MSVP, COO, CFOS - Sale$22.35-5,938253,221-2%-$132,714
2020-02-18
WVEWave Life Sciences Ltd.Panzara Michael A.Chief Medical OfficerS - Sale$7.85-2,98139,349-7%-$23,401
D
2020-02-18
GBTGlobal Blood Therapeutics, Inc.Lehrer-Graiwer JoshuaChief Medical OfficerS - Sale+OE$69.71-1,3132,595-34%-$91,529
2020-02-18
WVEWave Life Sciences Ltd.Bolno PaulPres, CEOS - Sale$7.85-11,451319,758-3%-$89,890
2020-02-18
WVEWave Life Sciences Ltd.Francis ChrisSee RemarksS - Sale$7.85-2,70831,160-8%-$21,258
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top